PARAGON-HF Clinical Trial Eligibility in a Population of Patients Hospitalized With Heart Failure: HFpEF Eligibility for PARAGON-HF

Sabina Sayeed; Marat Fudim; Adam D. Devore; Haolin Xu; Roland A. Matsouaka; Paul A. Heidenreich; Clyde W. Yancy; Gregg C. Fonarow; Adrian F. Hernandez

doi:10.1016/j.cardfail.2019.10.003

PARAGON-HF Clinical Trial Eligibility in a Population of Patients Hospitalized With Heart Failure: HFpEF Eligibility for PARAGON-HF

Sabina Sayeed, Marat Fudim, Adam D. Devore, Haolin Xu, Roland A. Matsouaka, Paul A. Heidenreich, Clyde W. Yancy, Gregg C. Fonarow, Adrian F. Hernandez^*

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Letter › peer-review

5 Scopus citations

Original language	English (US)
Pages (from-to)	1009-1011
Number of pages	3
Journal	Journal of Cardiac Failure
Volume	25
Issue number	12
DOIs	https://doi.org/10.1016/j.cardfail.2019.10.003
State	Published - Dec 2019

Funding

Funding: M. Fudim is supported by an American Heart Association Grant 17MCPRP33460225 and NIH T32 Grant 5T32HL007101. The Get With The Guidelines®-Heart Failure (GWTG-HF) program is provided by the American Heart Association. GWTG-HF is sponsored, in part, by Amgen Cardiovascular and has been funded in the past through support from Medtronic, GlaxoSmithKline, Ortho-McNeil, and the American Heart Association Pharmaceutical Roundtable. Powered by IQVIA, Cambridge, MA. Duke Clinical Research Institute (DCRI) served as the data analysis center.

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1016/j.cardfail.2019.10.003

Cite this

@article{fc9b2c900bf34c8fa77daee4fff5adda,

title = "PARAGON-HF Clinical Trial Eligibility in a Population of Patients Hospitalized With Heart Failure: HFpEF Eligibility for PARAGON-HF",

author = "Sabina Sayeed and Marat Fudim and Devore, {Adam D.} and Haolin Xu and Matsouaka, {Roland A.} and Heidenreich, {Paul A.} and Yancy, {Clyde W.} and Fonarow, {Gregg C.} and Hernandez, {Adrian F.}",

note = "Funding Information: Funding: M. Fudim is supported by an American Heart Association Grant 17MCPRP33460225 and NIH T32 Grant 5T32HL007101. Funding Information: The Get With The Guidelines{\textregistered}-Heart Failure (GWTG-HF) program is provided by the American Heart Association. GWTG-HF is sponsored, in part, by Amgen Cardiovascular and has been funded in the past through support from Medtronic, GlaxoSmithKline, Ortho-McNeil, and the American Heart Association Pharmaceutical Roundtable. Powered by IQVIA, Cambridge, MA. Duke Clinical Research Institute (DCRI) served as the data analysis center.",

year = "2019",

month = dec,

doi = "10.1016/j.cardfail.2019.10.003",

language = "English (US)",

volume = "25",

pages = "1009--1011",

journal = "Journal of Cardiac Failure",

issn = "1071-9164",

publisher = "Elsevier B.V.",

number = "12",

}

TY - JOUR

T1 - PARAGON-HF Clinical Trial Eligibility in a Population of Patients Hospitalized With Heart Failure

T2 - HFpEF Eligibility for PARAGON-HF

AU - Sayeed, Sabina

AU - Fudim, Marat

AU - Devore, Adam D.

AU - Xu, Haolin

AU - Matsouaka, Roland A.

AU - Heidenreich, Paul A.

AU - Yancy, Clyde W.

AU - Fonarow, Gregg C.

AU - Hernandez, Adrian F.

N1 - Funding Information: Funding: M. Fudim is supported by an American Heart Association Grant 17MCPRP33460225 and NIH T32 Grant 5T32HL007101. Funding Information: The Get With The Guidelines®-Heart Failure (GWTG-HF) program is provided by the American Heart Association. GWTG-HF is sponsored, in part, by Amgen Cardiovascular and has been funded in the past through support from Medtronic, GlaxoSmithKline, Ortho-McNeil, and the American Heart Association Pharmaceutical Roundtable. Powered by IQVIA, Cambridge, MA. Duke Clinical Research Institute (DCRI) served as the data analysis center.

PY - 2019/12

Y1 - 2019/12

UR - http://www.scopus.com/inward/record.url?scp=85075939914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075939914&partnerID=8YFLogxK

U2 - 10.1016/j.cardfail.2019.10.003

DO - 10.1016/j.cardfail.2019.10.003

M3 - Letter

C2 - 31626949

AN - SCOPUS:85075939914

SN - 1071-9164

VL - 25

SP - 1009

EP - 1011

JO - Journal of Cardiac Failure

JF - Journal of Cardiac Failure

IS - 12

ER -

PARAGON-HF Clinical Trial Eligibility in a Population of Patients Hospitalized With Heart Failure: HFpEF Eligibility for PARAGON-HF

Funding

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this